{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:25Z","timestamp":1788922225580,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM117425"],"award-info":[{"award-number":["GM117425"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 GM140223"],"award-info":[{"award-number":["T32 GM140223"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.molpha.2025.100079","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:24:34Z","timestamp":1758900274000},"page":"100079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effects of two structurally diverse positive allosteric modulators on signaling bias at the \u03bc-opioid receptor"],"prefix":"10.1016","volume":"107","author":[{"given":"Mengchu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6340-3822","authenticated-orcid":false,"given":"Kelsey E.","family":"Kochan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6010-5750","authenticated-orcid":false,"given":"M. Alexander","family":"Stanczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1659-7424","authenticated-orcid":false,"given":"Hannah C.","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1670-8196","authenticated-orcid":false,"given":"Joshua L.","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7176-038X","authenticated-orcid":false,"given":"Zara Y.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3177-4231","authenticated-orcid":false,"given":"Manojkumar A.","family":"Puthenveedu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1849-8316","authenticated-orcid":false,"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40122-018-0097-6","article-title":"A brief history of the opioid epidemic and strategies for pain medicine","volume":"7","author":"Jones","year":"2018","journal-title":"Pain Ther"},{"issue":"5449","key":"10.1016\/j.molpha.2025.100079_bib3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking \u03b2-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"6813","key":"10.1016\/j.molpha.2025.100079_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/35047086","article-title":"\u03bc-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence","volume":"408","author":"Bohn","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2025.100079_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in \u03b2-arrestin-2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"10.1016\/j.molpha.2025.100079_bib6","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molpha.2025.100079_bib7","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuron.2017.03.016","article-title":"Allosteric modulation of GPCRs: new insights and potential utility for treatment of schizophrenia and other CNS disorders","volume":"94","author":"Foster","year":"2017","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.molpha.2025.100079_bib8","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.tips.2020.09.009","article-title":"Critical assessment of G protein-biased agonism at the \u03bc-opioid receptor","volume":"41","author":"Gillis","year":"2020","journal-title":"Trends Pharmacol Sci"},{"issue":"7619","key":"10.1016\/j.molpha.2025.100079_bib9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.molpha.2025.100079_bib10","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphines","volume":"344","author":"DeWire","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/bph.12599","article-title":"Positive allosteric modulators of the \u03bc-opioid receptor: a novel approach for future pain medications","volume":"172","author":"Burford","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"14","key":"10.1016\/j.molpha.2025.100079_bib12","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1111\/bph.13823","article-title":"Allostery at opioid receptors: modulation with small molecule ligands","volume":"175","author":"Livingston","year":"2018","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib13","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1038\/s41467-024-47792-6","article-title":"Structural and dynamic insights into the activation of the \u03bc-opioid receptor by an allosteric modulator","volume":"15","author":"Kaneko","year":"2024","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.molpha.2025.100079_bib14","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2000017118","article-title":"Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side effects","volume":"118","author":"Kandasamy","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.molpha.2025.100079_bib15","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1210\/en.2011-1426","article-title":"Positive and negative allosteric modulators promote biased signaling at the calcium-sensing receptor","volume":"153","author":"Davey","year":"2012","journal-title":"Endocrinology"},{"issue":"8","key":"10.1016\/j.molpha.2025.100079_bib16","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrd4052","article-title":"Emerging paradigms in GPCR allostery: implications for drug discovery","volume":"12","author":"Wootten","year":"2013","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib17","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bph.12937","article-title":"Biased allosteric modulation at the CaS receptor engendered by structurally diverse calcimimetics","volume":"172","author":"Cook","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1124\/mol.115.099192","article-title":"Biased agonism and biased allosteric modulation at the CB1 cannabinoid receptor","volume":"88","author":"Khajehali","year":"2015","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.molpha.2025.100079_bib19","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1021\/acs.biochem.5c00022","article-title":"Mu opioid receptor positive allosteric modulator BMS-986122 confers agonist-dependent G protein subtype signaling bias","volume":"64","author":"Grieble","year":"2025","journal-title":"Biochemistry"},{"issue":"26","key":"10.1016\/j.molpha.2025.100079_bib20","doi-asserted-by":"crossref","first-page":"10830","DOI":"10.1073\/pnas.1300393110","article-title":"Discovery of positive allosteric modulators and silent allosteric modulators of the \u03bc-opioid receptor","volume":"110","author":"Burford","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/j.molpha.2025.100079_bib21","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1021\/acs.jmedchem.5b00007","article-title":"Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the \u03b4-opioid receptor","volume":"58","author":"Burford","year":"2015","journal-title":"J Med Chem"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1021\/acschemneuro.4c00541","article-title":"Structure-activity relationships and molecular pharmacology of positive allosteric modulators of the mu-opioid receptor","volume":"16","author":"Li","year":"2025","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14611","article-title":"Endogenous opioids regulate moment-to-moment neuronal communication and excitability","volume":"8","author":"Winters","year":"2017","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib24","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0022-3565(25)20831-X","article-title":"Pharmacological actions of a novel mixed opiate agonist\/antagonist: naloxone benzoylhydrazone","volume":"251","author":"Gistrak","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib25","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1124\/mol.117.109561","article-title":"Pharmacologic evidence for a putative conserved allosteric site on opioid receptors","volume":"93","author":"Livingston","year":"2018","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/07391102.2017.1417914","article-title":"Molecular mechanisms of allosteric probe dependence in \u03bc opioid receptor","volume":"37","author":"Bartuzi","year":"2019","journal-title":"J Biomol Struct Dyn"},{"issue":"51","key":"10.1016\/j.molpha.2025.100079_bib27","doi-asserted-by":"crossref","first-page":"18369","DOI":"10.1073\/pnas.1415013111","article-title":"Disruption of the Na+ ion binding site as a mechanism for positive allosteric modulation of the mu-opioid receptor","volume":"111","author":"Livingston","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"10.1016\/j.molpha.2025.100079_bib28","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1021\/acs.biochem.1c00466","article-title":"Low intrinsic Efficacy alone cannot explain the improved side effect profiles of new opioid agonists","volume":"61","author":"Stahl","year":"2022","journal-title":"Biochemistry"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib29","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41386-019-0491-8","article-title":"A G protein signaling-biased agonist at the \u03bc-opioid receptor reverses morphine tolerance while preventing morphine withdrawal","volume":"45","author":"Grim","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.molpha.2025.100079_bib30","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1091\/mbc.e12-07-0550","article-title":"Divergent modes for cargo-mediated control of clathrin-coated pit dynamics","volume":"24","author":"Soohoo","year":"2013","journal-title":"Mol Biol Cell"},{"issue":"11","key":"10.1016\/j.molpha.2025.100079_bib31","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1074\/jbc.M208885200","article-title":"Endogenous RGS protein action modulates \u03bc-opioid signaling through G\u03b1o. Effects on adenylyl cyclase, extracellular signal-regulated kinases, and intracellular calcium pathways","volume":"278","author":"Clark","year":"2003","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.molpha.2025.100079_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1124\/mol.117.108787","article-title":"A scale of agonism and allosteric modulation for assessment of selectivity, bias, and receptor mutation","volume":"92","author":"Kenakin","year":"2017","journal-title":"Mol Pharmacol"},{"issue":"4","key":"10.1016\/j.molpha.2025.100079_bib33","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1124\/mol.110.066613","article-title":"\u03bc-opioid receptors: correlation of agonist efficacy for signalling with ability to activate internalization","volume":"78","author":"McPherson","year":"2010","journal-title":"Mol Pharmacol"},{"issue":"5","key":"10.1016\/j.molpha.2025.100079_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1124\/mol.119.115956","article-title":"A biased view of \u03bc-opioid receptors?","volume":"96","author":"Conibear","year":"2019","journal-title":"Mol Pharmacol"},{"issue":"11","key":"10.1016\/j.molpha.2025.100079_bib35","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1111\/bph.14602","article-title":"The \u03b4-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist","volume":"176","author":"Stanczyk","year":"2019","journal-title":"Br J Pharmacol"},{"issue":"10","key":"10.1016\/j.molpha.2025.100079_bib36","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.bcp.2011.03.001","article-title":"Distinct pharmacological properties of morphine metabolites at Gi-protein and \u03b2-arrestin signaling pathways activated by the human \u03bc-opioid receptor","volume":"81","author":"Fr\u00f6lich","year":"2011","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10.1016\/j.molpha.2025.100079_bib37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1087057111406548","article-title":"Understanding the effect of different assay formats on agonist parameters: a study using the \u03bc-opioid receptor","volume":"16","author":"Nickolls","year":"2011","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.molpha.2025.100079_bib38","doi-asserted-by":"crossref","DOI":"10.1177\/1744806916654146","article-title":"Characterization of methadone as a \u03b2-arrestin-biased \u03bc-opioid receptor agonist","volume":"12","author":"Doi","year":"2016","journal-title":"Mol Pain"},{"issue":"21","key":"10.1016\/j.molpha.2025.100079_bib39","doi-asserted-by":"crossref","first-page":"11820","DOI":"10.1073\/pnas.2000712117","article-title":"Biased signaling by endogenous opioid peptides","volume":"117","author":"Gomes","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib40","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/molecules26010013","article-title":"Pharmacological characterization of \u03bc-opioid receptor agonists with biased G protein or \u03b2-arrestin signaling, and computational study of conformational changes during receptor activation","volume":"26","author":"Piekielna-Ciesielska","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.molpha.2025.100079_bib41","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1124\/mol.112.078659","article-title":"Endomorphin-2: a biased agonist at the \u03bc-opioid receptor","volume":"82","author":"Rivero","year":"2012","journal-title":"Mol Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15258-z","article-title":"A complementary scale of biased agonism for agonists with differing maximal responses","volume":"7","author":"Burgue\u00f1o","year":"2017","journal-title":"Sci Rep"},{"issue":"18","key":"10.1016\/j.molpha.2025.100079_bib43","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1111\/bph.16084","article-title":"Carfentanil is a \u03b2-arrestin-biased agonist at the \u03bc opioid receptor","volume":"180","author":"Ramos-Gonzalez","year":"2023","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.molpha.2025.100079_bib44","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/bph.13441","article-title":"Biased ligand quantification in drug discovery: from theory to high throughput screening to identify new biased \u03bc opioid receptor agonists","volume":"173","author":"Winpenny","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.molpha.2025.100079_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113910","article-title":"Assessment of structure-activity relationships and biased agonism at the Mu opioid receptor of novel synthetic opioids using a novel, stable bio-assay platform","volume":"177","author":"Vasudevan","year":"2020","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"10.1016\/j.molpha.2025.100079_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71228-y","article-title":"The operational model of allosteric modulation of pharmacological agonism","volume":"10","author":"Jakub\u00edk","year":"2020","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.molpha.2025.100079_bib47","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ncb3307","article-title":"\u03b2-arrestin drives MAP kinase signalling from clathrin-coated structures after GPCR dissociation","volume":"18","author":"Eichel","year":"2016","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.molpha.2025.100079_bib51","article-title":"Structural and dynamic studies uncover a distinct allosteric modulatory site at the \u03bc-opioid receptor","author":"Zhang","year":"2025","journal-title":"bioRxiv"},{"issue":"19","key":"10.1016\/j.molpha.2025.100079_bib48","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1021\/acschemneuro.0c00407","article-title":"Comparison of pharmacological properties between the kappa opioid receptor agonist nalfurafine and 42B, its 3-dehydroxy analogue: disconnect between in vitro agonist bias and in vivo pharmacological effects","volume":"11","author":"Cao","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.molpha.2025.100079_bib49","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-pharmtox-052120-091058","article-title":"Biased agonism: lessons from studies of opioid receptor agonists","volume":"63","author":"Kelly","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"S1","key":"10.1016\/j.molpha.2025.100079_bib50","doi-asserted-by":"crossref","DOI":"10.1096\/fasebj.2019.33.1_supplement.666.5","article-title":"The opioid receptor positive allosteric modulator BMS-986187 enhances some, but not all, delta-opioid receptor mediated behaviors","volume":"33","author":"Jutkiewicz","year":"2019","journal-title":"FASEB J"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25156393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X25156393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T10:14:34Z","timestamp":1763979274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X25156393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":50,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0026895X25156393"],"URL":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100079","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of two structurally diverse positive allosteric modulators on signaling bias at the \u03bc-opioid receptor","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molpha.2025.100079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100079"}}